IGF1R and breast cancer: Up‐regulation of miR‐122 suppressed cell growth and cell‐cycle progression in breast cancer cell lines and suppressed tumorigenesis in vivo by targeting IGF1R and regulating the PI3K/Akt/mTOR/p70S6K pathway (Wang et al., 2012).